It is used to revascularize patients with intracranial large vessel obstruction (internal carotid artery, middle cerebral artery - segments M1 and M2, basilar artery, and intravertebral artery) secondary to acute ischemic stroke, and must be performed within 8 hours of symptom onset. Patients who cannot be treated with intravenous tissue-type fibrinogen activator (IVt-PA) or who have failed IVt-PA therapy are candidates for this treatment.
Hydrophilic coating and smooth surface; good push and bend resistance; good distal flexibility and proximal support.